Last update 24 Dec 2024

Recombinant human neuregulin-1 (Zensun (Shanghai))

Overview

Basic Info

Drug Type
Recombinant polypeptide
Synonyms
Neucardin, Recombinant human neuregulin-1 beta, Recombinant Human Neuregulin-1β
+ [3]
Target
Mechanism
NRG1 modulators(Neuregulin-1 modulators)
Therapeutic Areas
Inactive Organization-
Drug Highest PhasePhase 3
First Approval Date-
Regulation-
Login to view timeline

R&D Status

10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
Heart FailureNDA/BLA
CN
17 Apr 2012
Heart Failure, DiastolicPhase 3
US
30 Jan 2022
Chronic congestive heart failurePhase 3
CN
01 Apr 2010
Chronic heart failurePhase 3
CN
01 Apr 2010
Chronic systolic heart failurePhase 3
CN
01 Apr 2010
Heart failure with normal ejection fractionPhase 2
CN
03 Nov 2022
Myocardial InfarctionIND Application
CN
30 Jan 2022
NeurilemmomaPreclinical
CN
12 Mar 2020
StrokePreclinical
CN
17 Dec 2018
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date
Phase 3
-
纽兰格林
bqccvepngr(rhhkbicjup): P-Value = >0.05
Negative
30 Jun 2022
Placebo
Phase 3
679
nukmhensvl(mcezczioxv) = lktcbnqwmk dzktzinyrg (xyweqkldvk )
Positive
08 Mar 2018
Placebo
nukmhensvl(mcezczioxv) = dzutymfuff dzktzinyrg (xyweqkldvk )
Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
Understand key drug designations in just a few clicks with Synapse.
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free